IHH Healthcare’s net income doubles net income to $152.1m in 3Q23

The company attributed the higher net income to higher patient volumes and improved case mix.

SGX-listed IHH Healthcare more than doubled its net income in 3Q23, earning RM532.1m ($152.1m).

The company attributed its higher net income to higher patient volumes and improved case mix.

In the same period, IHH Healthcare's revenue and earnings before interest, taxes, depreciation, and amortisation (EBITDA) grew double digits.

In 3Q23, the company’s revenue rose 27% YoY to RM5.8b ($1.7b), whilst its EBITDA jumped 42% YoY to RM1.4b ($400m).

Following its stellar performance in 3Q23, the company paid its shareholders an Interim cash dividend of 3.5 sen ($0.010) per ordinary share on 27 October.

1 SGD = 3.50 RM

Follow the link for more news on

IHH Healthcare

Financial Statements

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia